CAS No.352458-37-8 Pharmaceutical Intermediates
Product detail
ABT-492 meglumine is a novel compound that combines the properties of an active pharmaceutical ingredient (API) with the solubility and stability properties of meglumine. This formulation is particularly effective in improving the bioavailability of poorly soluble drugs, making it a valuable asset for the development of injectable and other dosage forms. ABT-492 meglumine is primarily used to treat various cancers, providing healthcare professionals with a powerful tool to improve patient outcomes.
product detail
|
CAS No. |
40856-44-8 |
|
EINECS |
609-874-3 |
|
Formula |
C9H11NO2 |
|
Molecular Weight |
165.19 |
|
Appearance |
White to Off-White solid |
|
Purity |
≥98% |
|
Type |
Pharmaceutical Intermediates |
As a factory integrating production and trading, we are committed to providing high-quality products and excellent customer service. Our dedication to innovation and excellence makes us stand out in the pharmaceutical industry. By choosing ABT-492 Meglumine from our company, you are not only investing in a quality product, but also working with a reliable supplier who is committed to your success.
In summary, ABT-492 meglumine is a breakthrough compound that offers numerous advantages for pharmaceutical applications. With its high purity, stability, and enhanced bioavailability, it is expected to have a significant impact in the development of effective therapeutic agents. Trust our company to provide you with the quality and service you need to excel in the pharmaceutical field. Experience the benefits of ABT-492 meglumine and take your formulations to new heights.



